NDC 52609-4505-6 Deferoxamine Mesylate

NDC Package Code 52609-4505-6

The NDC Code 52609-4505-6 is assigned to a package of 4 injection, powder, lyophilized, for solution in 1 carton of Deferoxamine Mesylate, labeled by Apopharma Usa, Inc.. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 4 billable units per package.

Field Name Field Value
NDC Code 52609-4505-6
Package Description 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON
Product Code 52609-4505
Proprietary Name Deferoxamine Mesylate What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Drug Uses This medication is used along with other treatments (such as causing vomiting with syrup of ipecac, stomach pumping) to treat sudden iron poisoning. It is most effective when given as soon as possible after the iron was eaten. This medication can also be used to help get rid of iron in patients with high iron levels due to many blood transfusions. Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists. It works by helping the kidneys and gallbladder get rid of the extra iron. This medication is not recommended for use in children less than 3 years old (see also Precautions section).
11-Digit NDC Billing Format 52609450506 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Billing Unit EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Estimated Billable Units per Package 4 EA
RxNorm Crosswalk
  • RxCUI: 1731345
  • RxCUI: 1731350
  • Labeler Name Apopharma Usa, Inc.
    Sample Package No Sample Package?
    This field Indicates whether this package is a sample packaging or not.
    Start Marketing Date 03-23-2018 What is the Start Marketing Date?
    This is the date that the labeler indicates was the start of its marketing of the drug product.
    Listing Expiration Date 12-31-2021 What is the Listing Expiration Date?
    This is the date when the listing record will expire if not updated or certified by the product labeler.
    Exclude Flag I What is the NDC Exclude Flag?
    This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
    This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

    NDC Code Structure

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 52609-4505-6 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    52609450506J0895Deferoxamine mesylate inj500 MG1414

    * Please review the disclaimer below.